Topic

Cometriq (cabozantinib)

A collection of 34 issues

How to Get Cometriq (cabozantinib) Covered by UnitedHealthcare in Michigan: Complete PA Guide with Forms and Appeals

Getting Cometriq (cabozantinib) covered by UnitedHealthcare in Michigan requires prior authorization for metastatic medullary thyroid carcinoma (MTC) or progressive thyroid cancers after failed step therapy. Submit via the UHC Provider Portal with diagnosis confirmation, or call 866-889-8054. If denied, you have 180 days for internal appeals and 127 days for
5 min read

How to Get Cometriq (Cabozantinib) Covered by UnitedHealthcare in North Carolina: Complete Prior Authorization & Appeals Guide

Answer Box: Getting Cometriq Covered by UnitedHealthcare in North Carolina UnitedHealthcare requires prior authorization for Cometriq (cabozantinib capsules) in North Carolina, primarily for progressive, metastatic medullary thyroid cancer (MTC). Submit PA through your oncologist via the UHC Provider Portal with pathology reports, imaging showing progression, and ICD-10 codes. If denied,
5 min read

How to Get Cometriq (Cabozantinib) Covered by Cigna in Pennsylvania: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Cometriq Covered by Cigna in Pennsylvania Cigna covers Cometriq (cabozantinib capsules) for metastatic medullary thyroid carcinoma with prior authorization. Your oncologist submits a PA request including pathology confirming MTC diagnosis, recent imaging showing progression, and elevated calcitonin/CEA levels. If denied, Pennsylvania's new Independent External
6 min read

How to Get Cometriq (cabozantinib) Covered by Blue Cross Blue Shield in New Jersey: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Cometriq Covered in New Jersey Cometriq (cabozantinib capsules) requires prior authorization from Blue Cross Blue Shield in New Jersey for metastatic medullary thyroid carcinoma. Your oncologist submits the PA electronically with pathology reports, imaging showing progression, and medical necessity documentation. If denied, you have 180 days to
6 min read

How to Get Cometriq (Cabozantinib) Covered by Blue Cross Blue Shield in Ohio: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Cometriq Covered in Ohio Blue Cross Blue Shield of Ohio (Anthem BCBS OH) requires prior authorization for Cometriq (cabozantinib capsules) for progressive/metastatic medullary thyroid carcinoma. First step: Verify your diagnosis meets criteria (confirmed MTC with progression, no active bleeding/GI issues). Fastest path: Submit PA via
6 min read

Renewing Cometriq (Cabozantinib) Approval with Blue Cross Blue Shield in Washington: Complete Timeline and Documentation Guide

Quick Answer: Blue Cross Blue Shield Washington typically requires renewal every 6-12 months for Cometriq (cabozantinib) with documented stable disease or response via imaging (CT/MRI every 2-3 months) and biochemical markers (calcitonin/CEA). Submit renewal 2-4 weeks before expiration through your oncologist with recent scans, lab trends, and toxicity
6 min read